E. E. Holdener

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: Results of a European multi-center phase III study

Sophie D. Fosså, Giovanni Martinelli, Ulrich Otto et al. · Annals of Oncology · 1992 · 127 citations

Medicine, Oncology, Pharmacology +15

Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinoma

Silvia Scalzo, Antonio Gengaro, G Boccoli et al. · European Journal of Cancer and Clinical Oncology · 1990 · 60 citations

Medicine, Endocrinology, Oncology +14

Interferon‐alpha and survival in renal cell cancer

Sophie D. Fosså, Monica Jones, Peter Johnson et al. · British Journal of Urology · 1995 · 42 citations

Medicine, Oncology, Radiation Oncology +13

Clinical experience with the combined use of recombinant interleukin‐2 (IL2) and interferon alfa‐2a (IFNα) in metastatic melanoma

Wim H.J. Kruit, S.H. Goey, J. R. T. Monson et al. · British Journal of Haematology · 1991 · 34 citations

Pharmacy, Oncology, Pharmacotherapy +17

Second Malignant Neoplasms in Operable Carcinoma of the Breast

E. E. Holdener, R Nissen-Meyer, Gianni Bonadonna et al. · Recent results in cancer research/Recent Results in Cancer Research · 1984 · 28 citations

Medicine, Oncology, Pathology +14